| FAIN, Olivier |
| Completed | 1/2 | 18 | Europe | low-dose IL-2, interleukin-2 | Assistance Publique - Hôpitaux de Paris, Iltoo Pharma | Recurrent Miscarriage | 07/23 | 03/24 | | |
MATAC, NCT06444477: Molecular Analysis of Thrombocytopenia and Cancer (): Investigating Antigenic Mimicry Between Platelets and Tumor Cells in Patients With Immune Thrombocytopenia (ITP) Associated With Cancer |
|
|
| Not yet recruiting | N/A | 70 | Europe | ITP and cancer | University Hospital, Bordeaux | Immune Thrombocytopenia, Immune Thrombocytopenic Purpura, Neoplasms, Cancer | 12/24 | 12/24 | | |
KIN-ACE, NCT04763577: Bradykinin-degradating Enzymes Activities in Angiotensin-Converting Enzyme Inhibitors-associated Angioedema |
|
|
| Recruiting | N/A | 243 | Europe | Assay of Bradykinin-degradating enzymes. | University Hospital, Grenoble, University Hospital, Paris, University Hospital, Rouen | Angio-Oedema Caused by Angiotensin-Converting-Enzyme Inhibitor | 04/25 | 04/25 | | |
NCT01034969: Firazyr® Patient Registry (Icatibant Outcome Survey - IOS) |
|
|
| Recruiting | N/A | 3000 | Europe, RoW | | Shire, Takeda Development Center Americas, Inc. | Hereditary Angioedema (HAE) | 01/27 | 01/27 | | |
| Mekinian, Arsene |
| Recruiting | 3 | 161 | Europe | Certolizumab (CIMZIA® ; TNF-α antagonist), Placebo (NaCl 0.9 % solution) | Assistance Publique - Hôpitaux de Paris, DGOS | Recurrent Unexplained Implantation Failure | 04/29 | 04/29 | | |
| Recruiting | 2 | 58 | Europe | tocilizumab and IV steroids combination, IV steroids combination alone | Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Roche Chugai | Giant Cell Arteritis, Optic Ischaemic Neuropathy | 11/20 | 12/22 | | |
TRIBECA, NCT04629144: Efficacy and Safety of Belimumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Compared to Placebo. STUDY (Treatment nd BElimumab in Cryoglobulinemia Associated Vasculitis) |
|
|
| Recruiting | 2 | 48 | Europe | Belimumab, Placebo | Assistance Publique - Hôpitaux de Paris | Vasculitis, Cryoglobulinemia | 04/25 | 10/25 | | |
| Completed | 1/2 | 18 | Europe | low-dose IL-2, interleukin-2 | Assistance Publique - Hôpitaux de Paris, Iltoo Pharma | Recurrent Miscarriage | 07/23 | 03/24 | | |
| Not yet recruiting | N/A | 1000 | NA | observational cohort study | Assistance Publique - Hôpitaux de Paris, Sorbonne University, Institut National de la Santé Et de la Recherche Médicale, France, Club MINHEMON (MEDECINE INTERNE, HEMATO ET ONCO) | Immune System Diseases, Autoimmune Diseases, Inflammation, Autoinflammatory Diseases, Vexas Syndrome, Hematopoiesis Clonal, Clonal Hematopoiesis of Indeterminate Potential, Hematologic Diseases, Myelodysplastic-Myeloproliferative Diseases, Leukemia Myelomonocytic Chronic, Myelodysplastic Syndromes, Myeloproliferative Disorders, Lymphoproliferative Disorders, Lymphoma, Leukemia, Monoclonal Gammopathy of Undetermined Significance | 09/43 | 09/43 | | |
FALCO, NCT05557201: Cohort of Patients Presenting Unexplained Recurrent Miscarriages and Identification of Early Miscarriage Recidivism Factors |
|
|
| Not yet recruiting | N/A | 500 | Europe | Lymphocyte immunophenotyping | Assistance Publique - Hôpitaux de Paris | Miscarriage | 10/24 | 10/25 | | |
| Lorenzon, Roberta |
| Recruiting | 2 | 24 | Europe | Cyclosporin, ILT101, Placebo | Assistance Publique - Hôpitaux de Paris, Iltoo Pharma | Type 1 Diabetes | 10/24 | 07/26 | | |
| Completed | 1/2 | 18 | Europe | low-dose IL-2, interleukin-2 | Assistance Publique - Hôpitaux de Paris, Iltoo Pharma | Recurrent Miscarriage | 07/23 | 03/24 | | |
